Nutex Health shares surge 10.43% intraday as strong revenue, earnings, and cash flow growth offset low valuation.

Nutex Health (NUTX) surged 10.43% intraday trading following a Bloomberg report highlighting its alignment with key growth investing criteria. The stock’s explosive revenue and earnings growth, coupled with soaring cash flow and a low valuation, positioned it as a high-conviction buy for investors seeking undervalued momentum plays. The report emphasized NUTX’s strong fundamentals as a catalyst for the sharp intraday rally, with analysts noting its potential for continued outperformance amid favorable market conditions for high-growth healthcare innovators.